acut
rhinosinus
ar
complex
entiti
exact
pathogenesi
still
partli
obscur
case
ar
involv
nasal
passag
paranas
virus
bacteria
involv
first
viral
infect
middl
meatal
pathogen
bacteri
coinfect
modifi
diseas
process
end
result
may
bacteri
secondari
infect
key
pathogen
process
ar
inflammatori
reaction
nasal
paranas
may
theoret
link
microbiolog
etiolog
spread
diseas
paranas
sinus
symptom
theori
biomark
parallel
local
system
inflammatori
reaction
could
shed
light
pathophysiolog
develop
bacteri
ar
peripher
blood
leucocyt
white
blood
cell
count
wbc
protein
crp
well
nasal
nitric
oxid
nno
suggest
possibl
biomark
diseas
activ
addit
proinflammatori
pct
propos
pertin
marker
bacteri
longitudin
studi
wild
experiment
cold
reveal
half
infect
subject
present
mild
increas
crp
studi
examin
whether
subject
develop
bacteri
other
shown
studi
microbiolog
confirm
bacteri
ar
associ
elev
crp
wbc
level
time
diagnosi
studi
follow
biomark
systemat
begin
ar
hypothes
systemat
sequenti
monitor
biomark
patient
singl
ar
episod
microbiolog
confirm
bacteri
ar
would
provid
view
pathophysiolog
ar
conduct
incept
cohort
studi
among
conscript
singl
episod
ar
took
sequenti
total
wbc
crp
pct
nno
count
aim
investig
biomark
level
ar
episod
particularli
relat
develop
bacteri
ar
look
relationship
biomark
level
microbiolog
clinic
find
determin
diagnost
accuraci
biomark
bacteri
ar
conduct
prospect
incept
cohort
studi
among
conscript
complet
compulsori
militari
servic
kainuu
brigad
northern
finland
patient
provid
written
inform
consent
studi
protocol
approv
ethic
committe
northern
ostrobothnia
hospit
district
finland
use
studi
popul
studi
clinic
imag
ar
briefli
patient
recruit
examin
health
center
kajaani
garrison
finland
particip
enrol
februari
april
consecut
conscript
sought
medic
care
due
ar
symptom
particip
ar
determin
follow
inclus
criteria
acut
onset
within
day
presenc
nasal
symptom
blockag
discharg
abnorm
nasal
find
mucos
edema
secret
patient
exclud
concomit
infect
necessit
antimicrobi
treatment
respiratori
infect
antimicrobi
treatment
within
week
preced
first
visit
nasal
allergi
asthma
requir
medic
chronic
nasal
symptom
polyp
prior
nasal
sinu
surgeri
particip
record
symptom
diari
presenc
sever
none
worst
possibl
acut
symptom
daili
follow
symptom
record
nasal
blockag
clear
nasal
discharg
purul
nasal
discharg
postnas
discharg
reductionloss
smell
facial
painpressur
diari
start
onset
symptom
sum
grade
symptom
obtain
total
symptom
score
paranas
comput
tomographi
cbct
scan
taken
enrol
visit
coron
axial
sagitt
slice
maxillari
ethmoid
sphenoid
sinus
ostiomeat
complex
omc
visual
side
paranas
sinus
grade
separ
follow
grade
normal
mm
mucos
thicken
grade
minor
abnorm
mm
mucos
thicken
point
grade
major
abnorm
level
ga
bubbl
total
opacif
ostiomeat
complex
omc
grade
open
occlud
determin
total
cbct
score
sum
grade
sinu
omc
side
took
sampl
multiplex
respiratori
viru
polymeras
chain
reaction
nasopharynx
visit
sinu
aspir
visit
search
conduct
respiratori
virus
took
middl
meatu
bacteri
sampl
visit
paranas
cbct
scan
visit
show
total
opacif
level
ga
bubbl
either
maxillari
sinu
patient
underw
maxillari
sinu
aspir
topic
anesthesia
aspir
cultur
identifi
bacteri
enrol
visit
took
blood
sampl
determin
wbc
count
concentr
pct
reflect
system
inflamm
addit
measur
level
nno
mirror
local
inflamm
analyz
wbc
count
use
automat
imped
flow
cytometri
analyz
celltac
nihon
kohden
ltd
tokyo
japan
photometr
immunochem
method
rochehitachi
modular
chemistri
analyz
hitachi
corpor
tokyo
japan
pct
use
chemiluminesc
immunoassay
advia
centaur
xp
siemen
healthcar
gmbh
erlangen
germani
minimum
detect
level
crp
pct
mgl
respect
level
nno
measur
electrochem
devic
niox
mino
nasal
aerocrin
solna
sweden
use
firm
nasal
oliv
direct
sampl
nasal
caviti
airstream
gener
analyz
breath
perform
patient
measur
maintain
velum
closur
prevent
nno
leakag
velopharyng
minimum
concentr
part
per
billion
right
left
nasal
count
use
subject
descript
data
calcul
median
interquartil
rang
test
chang
biomark
level
time
use
pair
wilcoxon
sign
rank
test
make
result
compar
wbc
pct
level
categor
similarli
earlier
use
nonparametr
u
test
test
compar
continu
variabl
correl
coeffici
calcul
use
spearman
rank
correl
coeffici
rs
viral
bacteri
sampl
analyz
per
patient
associ
bacteri
ar
rais
wbc
count
studi
calcul
sensit
specif
confid
interv
posit
neg
likelihood
ratio
lr
opportun
particip
offer
patient
consent
enrol
one
patient
exclud
pneumonia
detail
demograph
characterist
ar
episod
remain
patient
shown
tabl
seven
patient
return
symptom
diari
exclud
analys
symptom
twenti
patient
underw
maxillari
sinu
aspir
cultur
aspir
posit
nontyp
haemophilu
influenza
nthi
eight
case
thu
bacteri
ar
averag
pct
level
decreas
nno
level
increas
two
visit
indic
local
systemat
inflammatori
reaction
tabl
day
count
moder
correl
wbc
rs
p
pct
rs
p
nno
count
rs
p
age
sex
smoke
statu
associ
inflammatori
biomark
data
shown
day
subject
mildli
elev
level
moder
elev
level
day
proport
declin
respect
subject
nno
increas
two
visit
visit
significantli
larger
proport
subject
eventu
develop
bacteri
ar
elev
level
compar
subject
fig
howev
even
among
subject
bacteri
ar
median
level
markedli
higher
day
day
visit
subject
bacteri
ar
significantli
lower
median
level
nno
without
fig
wbc
count
show
similar
result
substanti
lower
proport
subject
elev
wbc
count
tabl
overwhelm
major
subject
procalcitonin
level
increas
refer
rang
ar
day
find
multipl
virus
adenoviru
influenza
viru
nasopharynx
associ
significantli
rais
valu
decreas
nno
level
tabl
spread
diseas
ostiomeat
occlus
shown
cbct
scan
associ
lower
nno
level
higher
level
day
presenc
nthi
sinu
aspir
associ
rais
valu
decreas
nno
valu
day
among
subject
main
symptom
score
correl
neither
nno
level
rs
p
rs
p
respect
howev
among
subject
bacteri
ar
strong
correl
found
level
main
symptom
score
rs
p
day
elev
mgl
predict
bacteri
ar
fairli
well
lr
moder
elev
mgl
well
lr
tabl
sensit
figur
find
howev
low
conduct
prospect
incept
cohort
studi
among
conscript
ar
measur
variou
inflammatori
biomark
day
symptom
day
aim
evalu
pathophysiolog
develop
bacteri
ar
clarifi
diagnost
usabl
biomark
found
signific
chang
pct
nno
level
two
visit
indic
presenc
local
system
inflammatori
respons
ar
signific
reciproc
correl
biomark
support
find
crp
nno
level
reflect
inflammatori
respons
best
half
subject
mildli
moder
increas
level
day
white
blood
cell
pct
count
exceed
refer
rang
rare
accord
nno
valu
local
system
inflammatori
respons
clearli
greatest
begin
symptom
compar
nonbacteri
ar
bacteri
ar
encompass
power
local
system
inflammatori
reaction
strongest
day
overal
found
increas
local
system
inflammatori
respons
link
multipl
adenovir
influenza
viral
etiolog
local
respons
system
respons
correl
strongli
spread
diseas
paranas
sinus
occlus
ostiomeat
complex
cbct
scan
bacteri
ar
found
system
inflammatori
respons
correl
power
symptom
score
begin
ar
may
indic
stronger
symptom
bacteri
ar
could
partli
result
enhanc
inflammatori
respons
fact
local
system
inflammatori
respons
stronger
bacteri
ar
nonbacteri
ar
reaction
strongest
begin
respiratori
symptom
indic
bacteri
ar
start
develop
earli
phase
symptom
agreement
earlier
find
gradual
increas
discrep
cbct
symptom
score
bacteri
nonbacteri
ar
begin
start
furthermor
shown
earlier
presenc
pathogen
bacteria
nasal
middl
meatu
coinfect
begin
viral
ar
modifi
symptom
one
factor
may
lead
find
bacteria
maxillari
howev
middl
meatal
nthi
associ
rais
crp
decreas
nno
rais
question
whether
pathogen
bacteria
alreadi
present
maxillari
sinu
begin
symptom
know
perform
maxillari
sinu
aspir
bacteri
cultur
visit
would
also
argu
gener
present
hypothesi
bacteri
ar
follow
anteced
viral
day
elev
mgl
predict
bacteri
ar
rel
well
lr
predict
moder
elev
mgl
well
lr
sensit
figur
find
low
earlier
examin
respect
figur
variou
symptom
clinic
find
compar
diagnost
measur
find
elev
crp
mgl
prove
better
predict
bacteri
ar
symptom
parallel
find
moder
profus
amount
nasal
secret
cervic
adenopathi
poorer
find
nasal
secret
posterior
pharynx
supplementari
materi
moder
elev
crp
mgl
accur
predict
bacteri
ar
present
four
patient
rel
high
neg
likelihood
ratio
absenc
elev
crp
could
use
rule
bacteri
ar
thu
crp
recommend
routin
screen
bacteri
ar
wbc
pct
count
rare
exceed
refer
valu
diagnost
valu
low
find
half
case
rais
valu
begin
ar
agre
whicher
et
al
melby
et
know
proport
patient
suffer
bacteri
ar
two
studi
research
look
presenc
bacteri
ar
nasopharyng
find
multipl
virus
adenoviru
influenza
viru
associ
inflammatori
respons
earlier
ruuskanen
et
al
found
elev
crp
influenza
adenoviru
infect
melby
influenza
savolainen
et
al
hansen
et
al
shown
clearli
patholog
valu
crp
associ
bacteri
ar
calcul
sensit
specif
predict
valu
patient
radiolog
sinus
found
lower
maxillari
sinu
level
control
one
propos
mechan
blockag
sinu
ostia
reduc
level
nasal
exhal
support
found
bacteri
ar
involv
lower
nno
level
nonbacteri
ar
ostiomeat
occlus
confirm
imag
associ
low
nno
level
minim
select
bia
recruit
consecut
patient
abl
verifi
viral
etiolog
subject
similar
prior
research
natur
perform
maxillari
sinu
aspir
everi
patient
cbct
find
support
bacteri
ar
might
caus
inform
bia
howev
ct
consid
best
imag
modal
evalu
paranas
sinu
defin
bacteri
ar
includ
maxillari
sinus
sinu
aspir
possibl
due
avail
resourc
studi
group
rel
small
despit
found
signific
associ
nno
level
variou
clinic
paramet
want
increas
possibl
encount
frequent
bacteri
ar
therefor
conscript
recruit
amount
patient
get
bacteri
sinus
ar
primari
care
usual
estim
would
need
patient
get
eight
case
bacteri
ar
studi
concern
generaliz
result
sever
issu
requir
recognit
due
militari
environ
conscript
men
smoke
common
correl
biomark
level
bacteria
found
maxillari
sinus
nthi
probabl
explain
fact
nthi
earlier
report
major
nasal
paranas
pathogen
among
finnish
overal
present
find
ar
involv
inflammatori
respons
warrant
reconfirm
among
patient
bacteria
acut
rhinosinus
particularli
bacteri
ar
involv
local
system
inflammatori
respons
strongest
begin
symptom
elev
support
diagnosi
bacteri
ar
